Labiana Health S.A. (LAB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Labiana Health S.A. (LAB) has a cash flow conversion efficiency ratio of 0.604x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€4.68 Million ≈ $5.47 Million USD) by net assets (€7.74 Million ≈ $9.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Labiana Health S.A. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Labiana Health S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Labiana Health S.A. for a breakdown of total debt and financial obligations.
Labiana Health S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Labiana Health S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gentian Diagnostics AS
OL:GENT
|
0.208x |
|
Unick Corporation
KQ:011320
|
0.058x |
|
ENERGY&MACHINERY KOREA Co.Ltd
KQ:095190
|
0.194x |
|
Netbay Public Company Limited
BK:NETBAY
|
0.159x |
|
Apollo Minerals Ltd
AU:AON
|
-0.137x |
|
Agripure Holdings Public Company Limited
BK:APURE
|
-0.003x |
|
Everbrite Technology Co Ltd
TWO:4523
|
-0.042x |
|
NEW STRATUS ENERGY
F:80N
|
-0.063x |
Annual Cash Flow Conversion Efficiency for Labiana Health S.A. (2021–2024)
The table below shows the annual cash flow conversion efficiency of Labiana Health S.A. from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see LAB company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €2.57 Million ≈ $3.00 Million |
€7.19 Million ≈ $8.41 Million |
2.801x | +622.10% |
| 2023-12-31 | €3.40 Million ≈ $3.98 Million |
€-1.83 Million ≈ $-2.13 Million |
-0.536x | -188.78% |
| 2022-12-31 | €7.74 Million ≈ $9.05 Million |
€4.68 Million ≈ $5.47 Million |
0.604x | +78.22% |
| 2021-12-31 | €11.52 Million ≈ $13.47 Million |
€3.91 Million ≈ $4.57 Million |
0.339x | -- |
About Labiana Health S.A.
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms,… Read more